VYNE - VYNE Therapeutics Inc
IEX Last Trade
1.835
0.025 1.362%
Share volume: 20,012
Last Updated: Fri 30 Aug 2024 09:59:19 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.81
0.03
1.38%
Summary score
28%
Profitability
25%
Dept financing
8%
Liquidity
75%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-41.89%
Return on assets
-19.19%
Return on sales
-11814.05%
Return on invested capital
203.82%
Total debt ratio
29.65%
Debt ratio change over timeo
-0.78%
Current Ratio
5.67%
Quick Ratio
5.54%
Cash Position Ratio
4.83%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-32.48%
Return on assets
-22.18%
Return on sales
-7407.54%
Return on invested capital
147.68%
Total debt ratio
22.33%
Debt ratio change over timeo
-0.85%
Current Ratio
8.02%
Quick Ratio
8.02%
Cash Position Ratio
7.6%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-7.5%
Return on assets
-8.05%
Return on sales
-7530.61%
Return on invested capital
114.1%
Total debt ratio
9.06%
Debt ratio change over time
-0.91%
Current Ratio
13.02%
Quick Ratio
13.02%
Cash Position Ratio
12.4%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-128.16%
Return on assets
-113.01%
Return on sales
-10222.69%
Return on invested capital
41.76%
Total debt ratio
-77.74%
Debt ratio change over time
-0.78%
Current Ratio
3.51%
Quick Ratio
3.41%
Cash Position Ratio
2.91%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | VYNE | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -41.89% | 18.83% | 17.34% | 7.6% |
| Return on assets | -19.19% | 4.16% | 8.21% | 3.22% |
| Return on sales | -11814.05% | 28.21% | 41.18% | 25.37% |
| Return on invested capital | 203.82% | 9.79% | -219.55% | 7.46% |
| Profitability | 25% | 56% | 73% | 36% |
| Total debt ratio | 29.65% | 82.89% | 55.88% | 60.02% |
| Debt ratio change over time | -0.78% | -4.38% | -0.73% | -33.74% |
| Dept financing | 9% | 25% | 42% | 18% |
| Current Ratio | 8.02% | 1.12% | 0% | 1.16% |
| Quick Ratio | 8.02% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 7.6% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 11% | 10% | 13% |
| Short-term ratios | VYNE | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -32.48% | 13.31% | 0% | 13.48% |
| Return on assets | -22.18% | 4.72% | 0% | 3.05% |
| Return on sales | -7407.54% | 31.4% | 0% | 25.56% |
| Return on invested capital | 147.68% | 10.68% | 0% | 13.96% |
| Profitability | 25% | 76% | 0% | 64% |
| Total debt ratio | 22.33% | 80.89% | 0% | 59.04% |
| Debt ratio change over time | -0.85% | -41.82% | 0% | 7.13% |
| Dept financing | 7% | 25% | 0% | 43% |
| Current Ratio | 8.02% | 1.12% | 0% | 1.16% |
| Quick Ratio | 8.02% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 7.6% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 7% | 0% | 8% |